These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 2849598

  • 1. Chemotherapy induction, consolidation radiotherapy and maintenance alternating chemotherapy in small cell carcinoma of the lung.
    Warner-Efrati E, Sulkes A, Weshler Z, Peretz T, Ben-Yosef R, Catane R, Biran S.
    Isr J Med Sci; 1988; 24(9-10):593-8. PubMed ID: 2849598
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Combination chemotherapy and radiation therapy for small cell carcinoma of the lung].
    Hara N, Ichinose Y, Motohiro A, Noge S, Miyake J, Ohta M, Hata K.
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):80-5. PubMed ID: 3002286
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y, Fukuoka M, Furuse K, Saijo N, Ikegami H, Nishiwaki Y, Tamura T, Shimoyama M, Suemasu K.
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC, McCrystal MR, Christmas TI.
    N Z Med J; 1998 Nov 27; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M, Erturk D.
    Saudi Med J; 2003 Jun 27; 24(6):628-31. PubMed ID: 12847592
    [Abstract] [Full Text] [Related]

  • 11. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R, Cetinayak HO, Sen RC, Demiral AN, Akkoçlu A, Osma E, Kargi A, Oztop I, Onen A, Kinay M, Dokuz Eylül Lung Cancer Study Group.
    J BUON; 2006 Jun 27; 11(1):31-7. PubMed ID: 17318949
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cyclic alternating chemotherapy for small cell carcinoma of the lung.
    Murray N, Shah A, Wilson K, Goldie J, Voss N, Fryer C, Klimo P, Coy P, Hadzic E, Gudauskas G.
    Cancer Treat Rep; 1985 Nov 27; 69(11):1241-2. PubMed ID: 3004724
    [Abstract] [Full Text] [Related]

  • 15. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
    Arcangeli G, Righini R, Nervi C, Guerra A, Tirindelli D, Hopkins H, Looney W.
    Cancer Treat Rep; 1985 Jan 27; 69(1):25-31. PubMed ID: 2981618
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A phase II clinical trial evaluating the use of two sequential, four-drug combination chemotherapy regimens in ambulatory bronchogenic adenocarcinoma patients.
    Broder LE, Sridhar KS, Selawry OS, Charyulu KN, Rao RK, Saldana MJ, Lenz C.
    Am J Clin Oncol; 1992 Dec 27; 15(6):480-6. PubMed ID: 1449109
    [Abstract] [Full Text] [Related]

  • 20. Combination versus alternating chemotherapy in small-cell lung cancer.
    Lai SL, Perng RP.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jul 27; 63(7):513-20. PubMed ID: 10934803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.